Dysregulation of MTs has been implicated in various diseases. Elevated levels of MTs are often found in cancers, where they may contribute to resistance against chemotherapy drugs. Conversely, reduced MT levels can lead to increased susceptibility to metal toxicity and oxidative stress, potentially contributing to neurodegenerative diseases and liver disorders. Understanding the balance of MT expression is crucial for developing therapeutic strategies.
